Michael Tatley

1.0k total citations
16 papers, 737 citations indexed

About

Michael Tatley is a scholar working on Toxicology, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Michael Tatley has authored 16 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Toxicology, 4 papers in Epidemiology and 4 papers in Economics and Econometrics. Recurrent topics in Michael Tatley's work include Pharmacovigilance and Adverse Drug Reactions (4 papers), Pharmaceutical Economics and Policy (3 papers) and Bacterial Infections and Vaccines (3 papers). Michael Tatley is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (4 papers), Pharmaceutical Economics and Policy (3 papers) and Bacterial Infections and Vaccines (3 papers). Michael Tatley collaborates with scholars based in New Zealand, United Kingdom and United States. Michael Tatley's co-authors include Merrick Zwarenstein, Ruth Savage, Carl Lombard, Yvonne Galloway, Anne McNicholas, Philipp Oster, Jane O’Hallahan, Ingeborg S. Aaberge, Johan Holst and Einar Rosenqvist and has published in prestigious journals such as The Lancet, Vaccine and Frontiers in Pharmacology.

In The Last Decade

Michael Tatley

16 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Tatley New Zealand	12	348	287	174	110	79	16	737
Yunxiao Shang China	20	360 1.0×	672 2.3×	108 0.6×	106 1.0×	20 0.3×	62	1.4k
Benjamin A. Kupronis United States	8	712 2.0×	359 1.3×	41 0.2×	34 0.3×	30 0.4×	12	1.1k
Elvis Temfack Cameroon	16	388 1.1×	416 1.4×	24 0.1×	42 0.4×	20 0.3×	50	820
Andreas Ackermann Germany	12	198 0.6×	137 0.5×	27 0.2×	107 1.0×	11 0.1×	28	640
F Mulcahy Ireland	19	594 1.7×	800 2.8×	59 0.3×	47 0.4×	24 0.3×	66	1.4k
Daniel A. Nafziger United States	11	110 0.3×	111 0.4×	17 0.1×	45 0.4×	48 0.6×	14	821
Robin Bruyndonckx Belgium	15	275 0.8×	140 0.5×	28 0.2×	210 1.9×	26 0.3×	47	731
Nathaniel Smith United States	15	299 0.9×	673 2.3×	55 0.3×	113 1.0×	57 0.7×	41	1.3k
Norberto Giglio Argentina	15	369 1.1×	125 0.4×	67 0.4×	15 0.1×	27 0.3×	64	665
Sarah C J Jorgensen Canada	21	306 0.9×	523 1.8×	28 0.2×	44 0.4×	10 0.1×	57	1.3k

Countries citing papers authored by Michael Tatley

Since Specialization

Citations

This map shows the geographic impact of Michael Tatley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Tatley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Tatley more than expected).

Fields of papers citing papers by Michael Tatley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Tatley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Tatley. The network helps show where Michael Tatley may publish in the future.

Co-authorship network of co-authors of Michael Tatley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Tatley. A scholar is included among the top collaborators of Michael Tatley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Tatley. Michael Tatley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ameratunga, Rohan, See‐Tarn Woon, Mary N. Sheppard, et al.. (2022). First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction. Journal of Clinical Immunology. 42(3). 441–447. 42 indexed citations

Bennett, Miriam, Catherina L. Chang, Michael Tatley, Ruth Savage, & Robert J. Hancox. (2021). The safety of cardioselective β₁-blockers in asthma: literature review and search of global pharmacovigilance safety reports. ERJ Open Research. 7(1). 801–2020. 20 indexed citations

Braund, Rhiannon, et al.. (2020). Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre. Clinical Toxicology. 59(6). 472–479. 10 indexed citations

Savage, Ruth, et al.. (2019). Suspected Hepatotoxicity With a Supercritical Carbon Dioxide Extract of Artemisia annua in Grapeseed Oil Used in New Zealand. Frontiers in Pharmacology. 10. 1448–1448. 13 indexed citations

Savage, Ruth & Michael Tatley. (2018). Case Series Analysis of New Zealand Reports of Rapid Intense Potentiation of Warfarin by Roxithromycin. Drug Safety. 41(5). 515–521. 2 indexed citations

Tatley, Michael, et al.. (2017). International Reports of Unexpected Low Plasma Concentrations of Dabigatran Suggest That More Frequent Measurements Will Add Value. Seminars in Thrombosis and Hemostasis. 43(6). 635–638. 2 indexed citations

Tatley, Michael, et al.. (2014). A new web-based Medication Error Reporting Programme (MERP) to supplement pharmacovigilance in New Zealand--findings from a pilot study in primary care.. PubMed. 127(1401). 69–81. 9 indexed citations

Holst, Johan, Philipp Oster, Richard Arnold, et al.. (2013). Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future. Human Vaccines & Immunotherapeutics. 9(6). 1241–1253. 175 indexed citations

Tatley, Michael, et al.. (2010). Detecting Medication Errors in the New Zealand Pharmacovigilance Database. Drug Safety. 34(1). 59–71. 20 indexed citations

10.

Tatley, Michael, Anne McNicholas, Lifeng Zhou, et al.. (2008). The Intensive Vaccines Monitoring Programme (IVMP): An electronic system to monitor vaccine safety in New Zealand. Vaccine. 26(22). 2746–2752. 12 indexed citations

11.

Harrison‐Woolrych, Mira, et al.. (2008). Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use.. PubMed. 121(1283). 76–89. 21 indexed citations

12.

Tatley, Michael & Ruth Savage. (2007). Psychiatric Adverse Reactions with Statins, Fibrates and Ezetimibe. Drug Safety. 30(3). 195–201. 64 indexed citations

13.

McNicholas, Anne, Yvonne Galloway, Paul A. Stehr‐Green, et al.. (2007). Post-Marketing Safety Monitoring of a New Group B Meningococcal Vaccine in New Zealand, 2004-2006. Human Vaccines. 3(5). 196–204. 28 indexed citations

14.

Zwarenstein, Merrick, et al.. (2000). A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis.. PubMed. 4(6). 550–4. 51 indexed citations

15.

Zwarenstein, Merrick, et al.. (1998). Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. The Lancet. 352(9137). 1340–1343. 193 indexed citations

16.

Beyers, Nulda, et al.. (1996). The use of a geographical information system (GIS) to evaluate the distribution of tuberculosis in a high-incidence community.. PubMed. 86(1). 40–1, 44. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact